Ranitidine Dosing
For adults, use ranitidine 150 mg orally twice daily or 50 mg IV every 6-8 hours; for children, use 2-4 mg/kg/day orally (maximum 300 mg/day) or 2-4 mg/kg/day IV divided every 6-8 hours (maximum 50 mg per dose); and for patients with creatinine clearance <50 mL/min, reduce to 150 mg orally every 24 hours or 50 mg IV every 18-24 hours. 1, 2
Adult Dosing
Oral Administration
- Standard dose: 150 mg twice daily for most indications (duodenal ulcer, gastric ulcer, GERD) 1
- Alternative: 300 mg once daily at bedtime for duodenal ulcer when dosing convenience is important 1
- Erosive esophagitis: 150 mg four times daily 1
- Maintenance therapy: 150 mg at bedtime 1
- Pathological hypersecretory conditions (e.g., Zollinger-Ellison): Start with 150 mg twice daily; may require more frequent dosing up to 6 g/day in severe disease 1
Intravenous/Intramuscular Administration
- Intermittent IV bolus: 50 mg every 6-8 hours, diluted to ≤2.5 mg/mL, injected over 5 minutes at ≤4 mL/min 2
- Intermittent IV infusion: 50 mg every 6-8 hours, diluted to ≤0.5 mg/mL, infused over 15-20 minutes 2
- Continuous IV infusion: 6.25 mg/hour (150 mg in 250 mL at 10.7 mL/hour) 2
- IM injection: 50 mg every 6-8 hours undiluted 2
- Zollinger-Ellison continuous infusion: Start at 1.0 mg/kg/hour, titrate upward in 0.5 mg/kg/hour increments if gastric acid output >10 mEq/hour; doses up to 2.5 mg/kg/hour have been used 2
Anaphylaxis Treatment
For adjunctive therapy in anaphylaxis (second-line to epinephrine): 50 mg IV in adults, diluted in 5% dextrose to 20 mL total volume, injected over 5 minutes 3
Pediatric Dosing
Oral Administration
- Treatment of duodenal/gastric ulcers: 2-4 mg/kg twice daily, maximum 300 mg/day 1
- Maintenance therapy: 2-4 mg/kg once daily, maximum 150 mg/day 1
- GERD and erosive esophagitis: 5-10 mg/kg/day in 2 divided doses 1
Critical consideration: Research suggests doses ≥3 mg/kg may be necessary for sustained acid suppression beyond 6 hours 4. In critically ill children, 1.5 mg/kg IV every 6 hours was more effective than lower doses for maintaining gastric pH >4 5.
Intravenous Administration
- Standard dose: 2-4 mg/kg/day divided every 6-8 hours, maximum 50 mg per dose 2
- Neonates on ECMO: 2 mg/kg every 12-24 hours or as continuous infusion 2
Anaphylaxis Treatment
For adjunctive therapy in anaphylaxis: 12.5-50 mg (1 mg/kg) IV, diluted in 5% dextrose to 20 mL, injected over 5 minutes 3
Renal Impairment Dosing
For creatinine clearance <50 mL/min:
- Oral: 150 mg every 24 hours; may increase frequency to every 12 hours with caution if clinically required 1
- IV: 50 mg every 18-24 hours; may increase to every 12 hours with caution 2
Important caveats:
- Hemodialysis minimally clears ranitidine; ideally time doses to coincide with end of dialysis 1, 2
- Research suggests current recommendations may be overly conservative—one study found dose reduction by half (rather than two-thirds) when creatinine clearance <10 mL/min may be more appropriate to avoid therapeutic failure while maintaining safety 6
- Monitor closely for adverse effects and adjust further if needed 1
Elderly Patients
Elderly patients are more likely to have decreased renal function. The elimination half-life increases to 3.1 hours (vs. 2.0-2.5 hours in younger adults) 2. Exercise caution in dose selection and monitor renal function; adjust doses according to creatinine clearance as outlined above 1, 2.
Key Clinical Pearls
- Onset of action: Gastric pH begins rising approximately 30 minutes after dosing, reaching peak effect within 35-50 minutes 7, 8
- Duration: Single doses maintain therapeutic effect for 6-8 hours in most patients 2
- Continuous infusion provides more consistent acid suppression than bolus dosing, particularly useful in critically ill patients 7
- Bioavailability: Oral bioavailability is approximately 50% in adults and 27.5% in children 2, 9
- Cardiac patients: Children with cardiac failure or post-cardiac surgery have significantly reduced clearance (by factor of 0.46) and may require dose reduction 9